HomeHealthFDA puts aging on its regulatory science agenda

FDA puts aging on its regulatory science agenda

By info@sportsmedical.news

October 2, 2026

51

At ARDD 2026, senior FDA officials sketch how a therapy targeting aging might one day reach approval, revealing that longevity is a priority.

Read the full story at Longevity.Technology »

Previous article

Colon cancer at 44: Michigan dad shares warning signs and why screening matters

Next article

What your mammogram can tell you about your heart

info@sportsmedical.news

RELATED ARTICLES

Most Popular

Recent Comments

Translate »